Cullinan Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGEM and other ETFs, options, and stocks.About CGEM
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617.
CEONadim Ahmed
CEONadim Ahmed
Employees111
Employees111
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2016
Founded2016
Employees111
Employees111
CGEM Key Statistics
Market cap703.60M
Market cap703.60M
Price-Earnings ratio-3.24
Price-Earnings ratio-3.24
Dividend yield—
Dividend yield—
Average volume1.30M
Average volume1.30M
High today$12.94
High today$12.94
Low today$11.90
Low today$11.90
Open price$12.38
Open price$12.38
Volume925.83K
Volume925.83K
52 Week high$13.33
52 Week high$13.33
52 Week low$5.68
52 Week low$5.68
Stock Snapshot
As of today, Cullinan Therapeutics(CGEM) shares are valued at $11.92. The company's market cap stands at 703.6M, with a P/E ratio of -3.24.
As of 2025-12-13, Cullinan Therapeutics(CGEM) stock has fluctuated between $11.90 and $12.94. The current price stands at $11.92, placing the stock +0.2% above today's low and -7.9% off the high.
Cullinan Therapeutics(CGEM) shares are trading with a volume of 925.83K, against a daily average of 1.3M.
In the last year, Cullinan Therapeutics(CGEM) shares hit a 52-week high of $13.33 and a 52-week low of $5.68.
In the last year, Cullinan Therapeutics(CGEM) shares hit a 52-week high of $13.33 and a 52-week low of $5.68.
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CGEM. This list is generated using Robinhood data, and it’s not a recommendation.